Karin Garre

Direktor/Vorstandsmitglied bei EXPRES2ION BIOTECH HOLDING AB

67 Jahre

Health Technology

Transportation

Consumer Services

Aktive Positionen von Karin Garre

Unternehmen	Position	Beginn	Ende
EXPRES2ION BIOTECH HOLDING AB	Direktor/Vorstandsmitglied	26.05.2021	-
EXPRES2ION BIOTECH HOLDING AB	Independent Dir/Board Member	26.05.2021	-
Symphogen A/S Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.	Corporate Officer/Principal	05.06.2020	-
	Geschäftsführer	01.04.2019	05.06.2020
Cervello A/S	Direktor/Vorstandsmitglied	-	-

Unternehmen	Position	Beginn	Ende
NTG NORDIC TRANSPORT GROUP A/S	Vorsitzender	01.12.2013	14.09.2018
NTG NORDIC TRANSPORT GROUP A/S	Independent Dir/Board Member	01.12.2013	14.09.2018
Lægernes Test Center A/S	Direktor/Vorstandsmitglied	-	-
StemCare Danmark A/S	Direktor/Vorstandsmitglied	-	-
StemCare A/S StemCare A/S BiotechnologyHealth Technology StemCare A/S operates as a private stem cell bank. The firm stores stem cells from umbilical cord blood. The company was founded by Sten Verland in 2003 and is headquartered in Gentofte, Denmark.	Direktor/Vorstandsmitglied	-	-
K:2 Holding ApS	Vorstandsvorsitzender	-	-

University of Copenhagen

Doctorate Degree

International

Dänemark

Operativ

Director/Board Member	5
Independent Dir/Board Member	2
Chief Executive Officer	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
NTG NORDIC TRANSPORT GROUP A/S	Transportation
EXPRES2ION BIOTECH HOLDING AB	Health Technology

Private Unternehmen	6
K:2 Holding ApS
StemCare Danmark A/S
StemCare A/S StemCare A/S BiotechnologyHealth Technology StemCare A/S operates as a private stem cell bank. The firm stores stem cells from umbilical cord blood. The company was founded by Sten Verland in 2003 and is headquartered in Gentofte, Denmark.	Health Technology
Lægernes Test Center A/S
Symphogen A/S Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.	Health Technology
Cervello A/S